

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 8.42405630 |
| 2 | drug transmembrane transport (GO:0006855) | 8.09048049 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.87586767 |
| 4 | exogenous drug catabolic process (GO:0042738) | 6.72629987 |
| 5 | drug transport (GO:0015893) | 6.67513747 |
| 6 | drug catabolic process (GO:0042737) | 6.60423898 |
| 7 | phosphate ion transport (GO:0006817) | 5.99860639 |
| 8 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.77677890 |
| 9 | organic cation transport (GO:0015695) | 5.73814846 |
| 10 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.60364579 |
| 11 | quaternary ammonium group transport (GO:0015697) | 5.57150851 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 5.48144299 |
| 13 | regulation of chronic inflammatory response (GO:0002676) | 5.40225959 |
| 14 | lysine metabolic process (GO:0006553) | 5.13648022 |
| 15 | lysine catabolic process (GO:0006554) | 5.13648022 |
| 16 | phosphate ion transmembrane transport (GO:0035435) | 5.12842522 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.98249062 |
| 18 | cysteine metabolic process (GO:0006534) | 4.86373474 |
| 19 | regulation of vitamin metabolic process (GO:0030656) | 4.78565667 |
| 20 | response to phenylpropanoid (GO:0080184) | 4.64925365 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.64204135 |
| 22 | valine metabolic process (GO:0006573) | 4.53629520 |
| 23 | vitamin D metabolic process (GO:0042359) | 4.47731590 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 4.47573786 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 4.41863531 |
| 26 | amino-acid betaine transport (GO:0015838) | 4.39448434 |
| 27 | carnitine transport (GO:0015879) | 4.39448434 |
| 28 | cellular response to type I interferon (GO:0071357) | 4.39164312 |
| 29 | type I interferon signaling pathway (GO:0060337) | 4.39164312 |
| 30 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.36202134 |
| 31 | response to type I interferon (GO:0034340) | 4.33520592 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.33458752 |
| 33 | phosphate ion homeostasis (GO:0055062) | 4.12942774 |
| 34 | trivalent inorganic anion homeostasis (GO:0072506) | 4.12942774 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12877168 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.06025406 |
| 37 | tricarboxylic acid metabolic process (GO:0072350) | 4.03893902 |
| 38 | excretion (GO:0007588) | 3.99286534 |
| 39 | regulation of fever generation (GO:0031620) | 3.95658478 |
| 40 | response to mercury ion (GO:0046689) | 3.94937669 |
| 41 | desmosome organization (GO:0002934) | 3.94285301 |
| 42 | positive regulation of heat generation (GO:0031652) | 3.92803692 |
| 43 | regulation of immunoglobulin secretion (GO:0051023) | 3.87744044 |
| 44 | beta-amyloid metabolic process (GO:0050435) | 3.86201641 |
| 45 | branched-chain amino acid metabolic process (GO:0009081) | 3.83619845 |
| 46 | toxin transport (GO:1901998) | 3.81582002 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79147981 |
| 48 | L-phenylalanine metabolic process (GO:0006558) | 3.79147981 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.78770037 |
| 50 | sodium-independent organic anion transport (GO:0043252) | 3.72833156 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 3.72187091 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.71390000 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.68297892 |
| 54 | L-phenylalanine catabolic process (GO:0006559) | 3.68297892 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 3.64505356 |
| 56 | myeloid dendritic cell differentiation (GO:0043011) | 3.63890597 |
| 57 | sphingoid metabolic process (GO:0046519) | 3.62822787 |
| 58 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.62161436 |
| 59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.60266513 |
| 60 | indole-containing compound catabolic process (GO:0042436) | 3.59318851 |
| 61 | indolalkylamine catabolic process (GO:0046218) | 3.59318851 |
| 62 | tryptophan catabolic process (GO:0006569) | 3.59318851 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.57944310 |
| 64 | tryptophan metabolic process (GO:0006568) | 3.56966759 |
| 65 | germinal center formation (GO:0002467) | 3.55159952 |
| 66 | proline metabolic process (GO:0006560) | 3.54983185 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.54354131 |
| 68 | renal absorption (GO:0070293) | 3.53649364 |
| 69 | peptide catabolic process (GO:0043171) | 3.52680033 |
| 70 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.52566502 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 3.49888408 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.48963146 |
| 73 | T-helper 1 type immune response (GO:0042088) | 3.48607770 |
| 74 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.47131382 |
| 75 | regulation of chemokine biosynthetic process (GO:0045073) | 3.45077522 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.42094593 |
| 77 | regulation of cholesterol homeostasis (GO:2000188) | 3.40480144 |
| 78 | NIK/NF-kappaB signaling (GO:0038061) | 3.37691043 |
| 79 | virion attachment to host cell (GO:0019062) | 3.36828782 |
| 80 | adhesion of symbiont to host cell (GO:0044650) | 3.36828782 |
| 81 | sulfur amino acid catabolic process (GO:0000098) | 3.36789763 |
| 82 | defense response to protozoan (GO:0042832) | 3.36569255 |
| 83 | acute-phase response (GO:0006953) | 3.35798242 |
| 84 | regulation of podosome assembly (GO:0071801) | 3.35273239 |
| 85 | response to peptidoglycan (GO:0032494) | 3.34915448 |
| 86 | carnitine metabolic process (GO:0009437) | 3.34886557 |
| 87 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.34851366 |
| 88 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.33783192 |
| 89 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.33352557 |
| 90 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.29970419 |
| 91 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29878534 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29878534 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 3.29651329 |
| 94 | negative regulation of amino acid transport (GO:0051956) | 3.28696625 |
| 95 | fatty acid oxidation (GO:0019395) | 3.28315813 |
| 96 | response to protozoan (GO:0001562) | 3.28060374 |
| 97 | regulation of mononuclear cell migration (GO:0071675) | 3.25674885 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25220187 |
| 99 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.24942153 |
| 100 | aspartate family amino acid catabolic process (GO:0009068) | 3.23284161 |
| 101 | epoxygenase P450 pathway (GO:0019373) | 3.22423606 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20957292 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 3.20507287 |
| 104 | complement activation, alternative pathway (GO:0006957) | 3.20358110 |
| 105 | lipid oxidation (GO:0034440) | 3.19703760 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19398586 |
| 107 | positive regulation of acute inflammatory response (GO:0002675) | 3.17595665 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.16116329 |
| 109 | negative regulation of growth of symbiont in host (GO:0044130) | 3.14729555 |
| 110 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.14729555 |
| 111 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.14729555 |
| 112 | regulation of growth of symbiont in host (GO:0044126) | 3.14729555 |
| 113 | modified amino acid transport (GO:0072337) | 3.14220236 |
| 114 | regulation of T-helper cell differentiation (GO:0045622) | 3.14035454 |
| 115 | adhesion of symbiont to host (GO:0044406) | 3.12301072 |
| 116 | carnitine transmembrane transport (GO:1902603) | 3.11954335 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 3.10279478 |
| 118 | positive regulation of type 2 immune response (GO:0002830) | 3.09698748 |
| 119 | ethanol oxidation (GO:0006069) | 3.08151232 |
| 120 | diol metabolic process (GO:0034311) | 3.06623323 |
| 121 | immunoglobulin mediated immune response (GO:0016064) | 3.05996952 |
| 122 | regulation of interleukin-12 production (GO:0032655) | 3.05167649 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 3.03603675 |
| 124 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.02652409 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 3.00667158 |
| 126 | fatty acid catabolic process (GO:0009062) | 2.98671495 |
| 127 | glycoside metabolic process (GO:0016137) | 2.98402401 |
| 128 | ethanol metabolic process (GO:0006067) | 2.98254103 |
| 129 | serine family amino acid metabolic process (GO:0009069) | 2.97775575 |
| 130 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.97276384 |
| 131 | negative regulation of viral genome replication (GO:0045071) | 2.96667073 |
| 132 | regulation of heat generation (GO:0031650) | 2.95721855 |
| 133 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.94845068 |
| 134 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.94494200 |
| 135 | fructose metabolic process (GO:0006000) | 2.94391116 |
| 136 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93255575 |
| 137 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.93204735 |
| 138 | fibrinolysis (GO:0042730) | 2.92991073 |
| 139 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.92971506 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92612172 |
| 141 | dendritic cell differentiation (GO:0097028) | 2.91885229 |
| 142 | cellular response to lipopolysaccharide (GO:0071222) | 2.91541421 |
| 143 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.90551838 |
| 144 | branched-chain amino acid catabolic process (GO:0009083) | 2.89899351 |
| 145 | chronic inflammatory response (GO:0002544) | 2.89250608 |
| 146 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88841485 |
| 147 | drug metabolic process (GO:0017144) | 2.88012562 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87792753 |
| 149 | sphingosine metabolic process (GO:0006670) | 2.85977857 |
| 150 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.85778296 |
| 151 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.85288268 |
| 152 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85068555 |
| 153 | metanephric tubule development (GO:0072170) | 2.84614624 |
| 154 | metanephric nephron tubule development (GO:0072234) | 2.84614624 |
| 155 | activation of MAPKKK activity (GO:0000185) | 2.84083589 |
| 156 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84011748 |
| 157 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.83489225 |
| 158 | bile acid biosynthetic process (GO:0006699) | 2.82442078 |
| 159 | biotin metabolic process (GO:0006768) | 2.80985334 |
| 160 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80121199 |
| 161 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.79396854 |
| 162 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78653293 |
| 163 | response to growth hormone (GO:0060416) | 2.78611694 |
| 164 | vitamin transport (GO:0051180) | 2.78143026 |
| 165 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77124644 |
| 166 | surfactant homeostasis (GO:0043129) | 2.76740845 |
| 167 | regulation of bile acid biosynthetic process (GO:0070857) | 2.76313369 |
| 168 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.75930448 |
| 169 | transcytosis (GO:0045056) | 2.74663663 |
| 170 | monocarboxylic acid catabolic process (GO:0072329) | 2.73268833 |
| 171 | glycosphingolipid catabolic process (GO:0046479) | 2.73174783 |
| 172 | positive regulation of interleukin-12 production (GO:0032735) | 2.72415577 |
| 173 | positive regulation of defense response to virus by host (GO:0002230) | 2.71223893 |
| 174 | cellular amino acid catabolic process (GO:0009063) | 2.70573161 |
| 175 | regulation of T-helper 1 type immune response (GO:0002825) | 2.70130819 |
| 176 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.69835879 |
| 177 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69716301 |
| 178 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.68397522 |
| 179 | transepithelial transport (GO:0070633) | 2.67362172 |
| 180 | hormone catabolic process (GO:0042447) | 2.67336637 |
| 181 | positive regulation of lipid storage (GO:0010884) | 2.67133379 |
| 182 | regulation of RIG-I signaling pathway (GO:0039535) | 2.66529374 |
| 183 | positive regulation of catenin import into nucleus (GO:0035413) | 2.66400464 |
| 184 | benzene-containing compound metabolic process (GO:0042537) | 2.66255274 |
| 185 | regulation of protein activation cascade (GO:2000257) | 2.65964982 |
| 186 | interferon-gamma secretion (GO:0072643) | 2.65922046 |
| 187 | sulfate transmembrane transport (GO:1902358) | 2.65092350 |
| 188 | sulfur compound transport (GO:0072348) | 2.64693329 |
| 189 | aromatic amino acid family metabolic process (GO:0009072) | 2.63609204 |
| 190 | cellular ketone body metabolic process (GO:0046950) | 2.63312489 |
| 191 | glutathione biosynthetic process (GO:0006750) | 2.62969772 |
| 192 | antibacterial humoral response (GO:0019731) | 2.61842576 |
| 193 | kynurenine metabolic process (GO:0070189) | 2.60078497 |
| 194 | pantothenate metabolic process (GO:0015939) | 2.59746470 |
| 195 | metanephric nephron epithelium development (GO:0072243) | 2.59584434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.69802516 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.53203886 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.26373698 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00663946 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66243219 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.51284992 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.01157955 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.94021570 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.85500159 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.65834924 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54275065 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46512592 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43405276 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.29874907 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28466760 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.24992428 |
| 17 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.18968569 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.15827517 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.09024358 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08947905 |
| 21 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.92313010 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88591313 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84712832 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.83857836 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.79325420 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75674616 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.75650607 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72401387 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72159672 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.70417096 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67387779 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66684428 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65876030 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63411709 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61718382 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60074663 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59534208 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59217709 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58400885 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58372318 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56948823 |
| 42 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.54157679 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52884608 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52757722 |
| 45 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50529046 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49788980 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48682414 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42440704 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41211792 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37995656 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37550377 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36609708 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36412459 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35545985 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33763987 |
| 56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.33222803 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29225733 |
| 58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28570749 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27942748 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27209171 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26325904 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24575703 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24255008 |
| 64 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24197141 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24047707 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23652940 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22408872 |
| 68 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.21122405 |
| 69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20500752 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20105318 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19824437 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19445593 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17696016 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16625515 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15639328 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15585010 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15208532 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.14750861 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14578405 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13707112 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13008025 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11691823 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11091565 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10443682 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10443682 |
| 86 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10125982 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10059321 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09735808 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09678007 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08937675 |
| 91 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07973081 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07597172 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07371220 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07327552 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07189675 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07072295 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05289492 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05243899 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05021676 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04443978 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03618463 |
| 102 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.03515275 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03499137 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03378716 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03168830 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03097288 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02890155 |
| 108 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02629913 |
| 109 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02629913 |
| 110 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02629913 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02169841 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 1.01976108 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01475316 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98873522 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97842696 |
| 116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97547107 |
| 117 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.96763806 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96445217 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96070965 |
| 120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95927315 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93527974 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93283633 |
| 123 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92592971 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92268440 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91663836 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90744135 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89906309 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89464040 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88947050 |
| 130 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87880187 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87790904 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87658998 |
| 133 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87183215 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87166609 |
| 135 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86259497 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86017158 |
| 137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86002016 |
| 138 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85545690 |
| 139 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85045749 |
| 140 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84964178 |
| 141 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.84930345 |
| 142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.84845297 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83230944 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83219842 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80348518 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80010023 |
| 147 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76557966 |
| 148 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.72310580 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70090590 |
| 150 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69591756 |
| 151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.69304964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.96143257 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.17653528 |
| 3 | MP0004043_abnormal_pH_regulation | 3.95919353 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 3.79689634 |
| 5 | MP0003724_increased_susceptibility_to | 3.64602452 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.47084639 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.44566625 |
| 8 | MP0005332_abnormal_amino_acid | 3.13944204 |
| 9 | MP0009785_altered_susceptibility_to | 3.13017985 |
| 10 | MP0004510_myositis | 3.12989022 |
| 11 | MP0009643_abnormal_urine_homeostasis | 3.08511269 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 3.01300435 |
| 13 | MP0006082_CNS_inflammation | 2.99324775 |
| 14 | MP0001765_abnormal_ion_homeostasis | 2.84659542 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.78393860 |
| 16 | MP0003436_decreased_susceptibility_to | 2.70274941 |
| 17 | MP0002136_abnormal_kidney_physiology | 2.67068873 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.58695512 |
| 19 | MP0003252_abnormal_bile_duct | 2.57496711 |
| 20 | MP0003868_abnormal_feces_composition | 2.46836333 |
| 21 | MP0009840_abnormal_foam_cell | 2.43789766 |
| 22 | MP0003195_calcinosis | 2.35932013 |
| 23 | MP0005671_abnormal_response_to | 2.27367223 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 2.26305733 |
| 25 | MP0002009_preneoplasia | 2.25492691 |
| 26 | MP0005365_abnormal_bile_salt | 2.25292325 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 2.20799847 |
| 28 | MP0001756_abnormal_urination | 2.19488748 |
| 29 | MP0005451_abnormal_body_composition | 2.18848703 |
| 30 | MP0005025_abnormal_response_to | 2.18174232 |
| 31 | MP0001790_abnormal_immune_system | 2.16407457 |
| 32 | MP0005387_immune_system_phenotype | 2.16407457 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 2.14774041 |
| 34 | MP0001958_emphysema | 2.01082380 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.98082301 |
| 36 | MP0002796_impaired_skin_barrier | 1.97654878 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.96952593 |
| 38 | MP0003075_altered_response_to | 1.93877005 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.93081607 |
| 40 | MP0002419_abnormal_innate_immunity | 1.92972455 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.87573654 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.86571460 |
| 43 | MP0008004_abnormal_stomach_pH | 1.84842051 |
| 44 | MP0001873_stomach_inflammation | 1.75419356 |
| 45 | MP0001800_abnormal_humoral_immune | 1.66072389 |
| 46 | MP0005310_abnormal_salivary_gland | 1.65178009 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.63893957 |
| 48 | MP0000604_amyloidosis | 1.57773196 |
| 49 | MP0000538_abnormal_urinary_bladder | 1.57503595 |
| 50 | * MP0001835_abnormal_antigen_presentation | 1.55676882 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.47969394 |
| 52 | MP0001853_heart_inflammation | 1.47773047 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.47339011 |
| 54 | MP0002254_reproductive_system_inflammat | 1.46228680 |
| 55 | MP0000343_altered_response_to | 1.42019965 |
| 56 | MP0005501_abnormal_skin_physiology | 1.37166035 |
| 57 | MP0009697_abnormal_copulation | 1.36878988 |
| 58 | MP0003878_abnormal_ear_physiology | 1.36854726 |
| 59 | MP0005377_hearing/vestibular/ear_phenot | 1.36854726 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34852651 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.32540421 |
| 62 | MP0000685_abnormal_immune_system | 1.31517269 |
| 63 | MP0004147_increased_porphyrin_level | 1.31209209 |
| 64 | MP0005166_decreased_susceptibility_to | 1.27884139 |
| 65 | MP0002928_abnormal_bile_duct | 1.27574041 |
| 66 | MP0006054_spinal_hemorrhage | 1.27501956 |
| 67 | MP0009278_abnormal_bone_marrow | 1.21903890 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.21643899 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.21643899 |
| 70 | MP0002098_abnormal_vibrissa_morphology | 1.20809818 |
| 71 | MP0002168_other_aberrant_phenotype | 1.20435160 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 1.17779318 |
| 73 | MP0002006_tumorigenesis | 1.17581669 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.15741452 |
| 75 | MP0004885_abnormal_endolymph | 1.13922363 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.13185661 |
| 77 | MP0004947_skin_inflammation | 1.11481405 |
| 78 | MP0002405_respiratory_system_inflammati | 1.10849659 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.10160480 |
| 80 | MP0003448_altered_tumor_morphology | 1.10154843 |
| 81 | MP0009763_increased_sensitivity_to | 1.09247449 |
| 82 | MP0003690_abnormal_glial_cell | 1.07684548 |
| 83 | * MP0002452_abnormal_antigen_presenting | 1.06747832 |
| 84 | MP0010329_abnormal_lipoprotein_level | 1.06544732 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.05889453 |
| 86 | MP0000377_abnormal_hair_follicle | 1.03477104 |
| 87 | MP0001542_abnormal_bone_strength | 1.02593068 |
| 88 | MP0001501_abnormal_sleep_pattern | 1.02491196 |
| 89 | MP0000537_abnormal_urethra_morphology | 1.02170789 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 1.01090466 |
| 91 | MP0005000_abnormal_immune_tolerance | 1.00055570 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.98979108 |
| 93 | MP0005535_abnormal_body_temperature | 0.98756758 |
| 94 | MP0000609_abnormal_liver_physiology | 0.97153463 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.94547665 |
| 96 | MP0005164_abnormal_response_to | 0.93587432 |
| 97 | MP0005408_hypopigmentation | 0.92558166 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.91997862 |
| 99 | MP0002135_abnormal_kidney_morphology | 0.91743431 |
| 100 | MP0002060_abnormal_skin_morphology | 0.91069314 |
| 101 | MP0000858_altered_metastatic_potential | 0.90657739 |
| 102 | MP0003011_delayed_dark_adaptation | 0.90600568 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.90463742 |
| 104 | MP0008874_decreased_physiological_sensi | 0.90257186 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.90248723 |
| 106 | MP0005266_abnormal_metabolism | 0.88053911 |
| 107 | MP0009764_decreased_sensitivity_to | 0.87907762 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.87696256 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.87011234 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.85748999 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.85508687 |
| 112 | MP0003646_muscle_fatigue | 0.84498233 |
| 113 | MP0003045_fibrosis | 0.82465660 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.82023673 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.81685541 |
| 116 | MP0002723_abnormal_immune_serum | 0.81202223 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.80418713 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.79750432 |
| 119 | MP0003866_abnormal_defecation | 0.79153904 |
| 120 | MP0005165_increased_susceptibility_to | 0.78064875 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.77384395 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.77140979 |
| 123 | * MP0002420_abnormal_adaptive_immunity | 0.76372566 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.75028722 |
| 125 | MP0003303_peritoneal_inflammation | 0.74138324 |
| 126 | MP0001663_abnormal_digestive_system | 0.73418009 |
| 127 | MP0005023_abnormal_wound_healing | 0.73200620 |
| 128 | MP0008469_abnormal_protein_level | 0.72922708 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.71494313 |
| 130 | * MP0001819_abnormal_immune_cell | 0.71322672 |
| 131 | * MP0000689_abnormal_spleen_morphology | 0.70800519 |
| 132 | MP0004883_abnormal_blood_vessel | 0.70231860 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.69561638 |
| 134 | MP0001764_abnormal_homeostasis | 0.69291113 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.69268957 |
| 136 | * MP0002398_abnormal_bone_marrow | 0.68934187 |
| 137 | MP0005670_abnormal_white_adipose | 0.67859463 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.67828402 |
| 139 | MP0003091_abnormal_cell_migration | 0.67514914 |
| 140 | MP0000249_abnormal_blood_vessel | 0.67404756 |
| 141 | MP0002396_abnormal_hematopoietic_system | 0.67321813 |
| 142 | MP0003879_abnormal_hair_cell | 0.65683357 |
| 143 | MP0005390_skeleton_phenotype | 0.65650653 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.64394023 |
| 145 | MP0009642_abnormal_blood_homeostasis | 0.63582269 |
| 146 | * MP0002429_abnormal_blood_cell | 0.63444253 |
| 147 | MP0010771_integument_phenotype | 0.62549656 |
| 148 | MP0003186_abnormal_redox_activity | 0.62027675 |
| 149 | * MP0000716_abnormal_immune_system | 0.61470342 |
| 150 | MP0002722_abnormal_immune_system | 0.59843651 |
| 151 | MP0001191_abnormal_skin_condition | 0.58513796 |
| 152 | MP0005647_abnormal_sex_gland | 0.58303492 |
| 153 | MP0003183_abnormal_peptide_metabolism | 0.58251399 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.56835544 |
| 155 | MP0000371_diluted_coat_color | 0.55944388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.39128162 |
| 2 | Increased circulating renin level (HP:0000848) | 6.31206146 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 5.95653985 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.68765609 |
| 5 | Optic neuritis (HP:0100653) | 5.68765609 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.67655021 |
| 7 | Metabolic alkalosis (HP:0200114) | 5.63834121 |
| 8 | Orchitis (HP:0100796) | 5.41873410 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 5.41508169 |
| 10 | Gout (HP:0001997) | 5.41266691 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 5.31124053 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.31124053 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.31124053 |
| 14 | Hypomagnesemia (HP:0002917) | 5.20910152 |
| 15 | Polyuria (HP:0000103) | 4.85653807 |
| 16 | Abnormality of renal excretion (HP:0011036) | 4.74710546 |
| 17 | Deep venous thrombosis (HP:0002625) | 4.72003596 |
| 18 | Abnormal urine output (HP:0012590) | 4.69156569 |
| 19 | Complement deficiency (HP:0004431) | 4.64076578 |
| 20 | Proximal tubulopathy (HP:0000114) | 4.60109069 |
| 21 | Glomerulonephritis (HP:0000099) | 4.58774030 |
| 22 | Myositis (HP:0100614) | 4.51270584 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.37870415 |
| 24 | Stomatitis (HP:0010280) | 4.35247044 |
| 25 | Abnormality of magnesium homeostasis (HP:0004921) | 4.14666908 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04915916 |
| 27 | Polydipsia (HP:0001959) | 3.91602788 |
| 28 | Abnormal drinking behavior (HP:0030082) | 3.91602788 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 3.90196038 |
| 30 | Gastrointestinal stroma tumor (HP:0100723) | 3.88802851 |
| 31 | Abnormality of renin-angiotensin system (HP:0000847) | 3.88506437 |
| 32 | Hyperglycinuria (HP:0003108) | 3.83450649 |
| 33 | Alkalosis (HP:0001948) | 3.81448685 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 3.74896934 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.72643369 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.67335497 |
| 37 | Intrahepatic cholestasis (HP:0001406) | 3.67260021 |
| 38 | Gangrene (HP:0100758) | 3.65737952 |
| 39 | Abnormality of complement system (HP:0005339) | 3.61864794 |
| 40 | Hyperuricemia (HP:0002149) | 3.61763362 |
| 41 | Increased purine levels (HP:0004368) | 3.61763362 |
| 42 | Loss of speech (HP:0002371) | 3.61123210 |
| 43 | Tetany (HP:0001281) | 3.55948520 |
| 44 | Keratoconjunctivitis (HP:0001096) | 3.55905874 |
| 45 | Renal salt wasting (HP:0000127) | 3.52364083 |
| 46 | Disinhibition (HP:0000734) | 3.46801398 |
| 47 | Hyperaldosteronism (HP:0000859) | 3.45484704 |
| 48 | Abnormality of macrophages (HP:0004311) | 3.41731218 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 3.38086369 |
| 50 | Generalized aminoaciduria (HP:0002909) | 3.29659077 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28544653 |
| 52 | Dehydration (HP:0001944) | 3.23354804 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20456071 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 3.20456071 |
| 55 | Increased IgM level (HP:0003496) | 3.15501365 |
| 56 | Colitis (HP:0002583) | 3.14470714 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.12598127 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 3.08135528 |
| 59 | Mutism (HP:0002300) | 3.02595818 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 3.01915075 |
| 61 | Nuclear cataract (HP:0100018) | 3.00786110 |
| 62 | Parakeratosis (HP:0001036) | 2.99813149 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96973116 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96973116 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96973116 |
| 66 | Vascular calcification (HP:0004934) | 2.94368532 |
| 67 | Hypokalemia (HP:0002900) | 2.86546588 |
| 68 | Increased serum ferritin (HP:0003281) | 2.85603890 |
| 69 | Vasculitis (HP:0002633) | 2.85346627 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84393794 |
| 71 | Pulmonary embolism (HP:0002204) | 2.83549053 |
| 72 | Hypercalciuria (HP:0002150) | 2.82961922 |
| 73 | Renal tubular acidosis (HP:0001947) | 2.82194869 |
| 74 | Glycosuria (HP:0003076) | 2.81271541 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.81271541 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.76974884 |
| 77 | IgM deficiency (HP:0002850) | 2.76437506 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.75171872 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.75171872 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.73303934 |
| 81 | Abnormality of the fingertips (HP:0001211) | 2.72521544 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71826388 |
| 83 | Ketoacidosis (HP:0001993) | 2.69931044 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.69759733 |
| 85 | Nephritis (HP:0000123) | 2.69690364 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.68979432 |
| 87 | Ketosis (HP:0001946) | 2.68189269 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67642391 |
| 89 | Hypobetalipoproteinemia (HP:0003563) | 2.66653349 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.61082028 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 2.59991267 |
| 92 | Widely patent fontanelles and sutures (HP:0004492) | 2.58505848 |
| 93 | Purpura (HP:0000979) | 2.57564951 |
| 94 | Joint swelling (HP:0001386) | 2.55337068 |
| 95 | Arterial thrombosis (HP:0004420) | 2.54069276 |
| 96 | Anorexia (HP:0002039) | 2.53911412 |
| 97 | Nausea (HP:0002018) | 2.53675311 |
| 98 | Emphysema (HP:0002097) | 2.53673468 |
| 99 | Recurrent sinusitis (HP:0011108) | 2.51799786 |
| 100 | Abnormality of potassium homeostasis (HP:0011042) | 2.50832584 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.50297213 |
| 102 | Lymphopenia (HP:0001888) | 2.49211193 |
| 103 | Malnutrition (HP:0004395) | 2.47537918 |
| 104 | IgA deficiency (HP:0002720) | 2.43425558 |
| 105 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43105539 |
| 106 | Rickets (HP:0002748) | 2.42397127 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 2.41850767 |
| 108 | Axonal loss (HP:0003447) | 2.40923493 |
| 109 | Mitral stenosis (HP:0001718) | 2.39301533 |
| 110 | Hyperglycinemia (HP:0002154) | 2.37827847 |
| 111 | Encephalitis (HP:0002383) | 2.34573231 |
| 112 | Delayed epiphyseal ossification (HP:0002663) | 2.32979442 |
| 113 | Neurofibrillary tangles (HP:0002185) | 2.32633290 |
| 114 | Hemoptysis (HP:0002105) | 2.32434302 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.32409830 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.31999485 |
| 117 | Nephrocalcinosis (HP:0000121) | 2.28349610 |
| 118 | Nephrolithiasis (HP:0000787) | 2.27685607 |
| 119 | Hypophosphatemia (HP:0002148) | 2.27381432 |
| 120 | Abnormal hemoglobin (HP:0011902) | 2.26830147 |
| 121 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26207800 |
| 122 | Sensorimotor neuropathy (HP:0007141) | 2.25371571 |
| 123 | Polyneuropathy (HP:0001271) | 2.23301046 |
| 124 | Recurrent bronchitis (HP:0002837) | 2.23114509 |
| 125 | Autoimmune hemolytic anemia (HP:0001890) | 2.22644347 |
| 126 | Amyloidosis (HP:0011034) | 2.22019731 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 2.20124070 |
| 128 | Progressive neurologic deterioration (HP:0002344) | 2.19770249 |
| 129 | Prolonged neonatal jaundice (HP:0006579) | 2.17846847 |
| 130 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16770142 |
| 131 | Thin bony cortex (HP:0002753) | 2.16733410 |
| 132 | Chondrocalcinosis (HP:0000934) | 2.13552299 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 2.13501425 |
| 134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13017481 |
| 135 | Myocardial infarction (HP:0001658) | 2.12131985 |
| 136 | Abnormality of the pericardium (HP:0001697) | 2.10347230 |
| 137 | Hyperphosphaturia (HP:0003109) | 2.10242480 |
| 138 | Abnormality of the pleura (HP:0002103) | 2.09749992 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09576978 |
| 140 | Hyperammonemia (HP:0001987) | 2.08897172 |
| 141 | Abnormal urine phosphate concentration (HP:0012599) | 2.08146175 |
| 142 | Elevated alkaline phosphatase (HP:0003155) | 2.07773159 |
| 143 | Metaphyseal irregularity (HP:0003025) | 2.06579043 |
| 144 | Abnormal foot bone ossification (HP:0010675) | 2.06238531 |
| 145 | Chronic diarrhea (HP:0002028) | 2.04151905 |
| 146 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.03531681 |
| 147 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02316129 |
| 148 | Abnormality of Sharpey fibers (HP:0100685) | 2.01708201 |
| 149 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01668694 |
| 150 | Potter facies (HP:0002009) | 2.01567155 |
| 151 | Facial shape deformation (HP:0011334) | 2.01567155 |
| 152 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01025269 |
| 153 | Recurrent viral infections (HP:0004429) | 2.00659685 |
| 154 | Abnormality of carpal bone ossification (HP:0006257) | 2.00462603 |
| 155 | Basal ganglia calcification (HP:0002135) | 2.00130551 |
| 156 | Steatorrhea (HP:0002570) | 2.00103527 |
| 157 | Fat malabsorption (HP:0002630) | 1.99499765 |
| 158 | Lymphangioma (HP:0100764) | 1.99433436 |
| 159 | Xanthomatosis (HP:0000991) | 1.99294543 |
| 160 | Cellulitis (HP:0100658) | 1.99065573 |
| 161 | Thrombophlebitis (HP:0004418) | 1.98894935 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98742394 |
| 163 | Memory impairment (HP:0002354) | 1.98585432 |
| 164 | Hematochezia (HP:0002573) | 1.98098118 |
| 165 | Verrucae (HP:0200043) | 1.97784283 |
| 166 | Papilloma (HP:0012740) | 1.97784283 |
| 167 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95956150 |
| 168 | Meningitis (HP:0001287) | 1.93123960 |
| 169 | Hyponatremia (HP:0002902) | 1.92218315 |
| 170 | Acne (HP:0001061) | 1.92146340 |
| 171 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91663693 |
| 172 | Petechiae (HP:0000967) | 1.90441108 |
| 173 | Autoimmune thrombocytopenia (HP:0001973) | 1.90008041 |
| 174 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89225208 |
| 175 | Apathy (HP:0000741) | 1.88974032 |
| 176 | Pancreatitis (HP:0001733) | 1.87194562 |
| 177 | Small epiphyses (HP:0010585) | 1.87093506 |
| 178 | Arthralgia (HP:0002829) | 1.87042617 |
| 179 | Confusion (HP:0001289) | 1.85515794 |
| 180 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.84659814 |
| 181 | Tubulointerstitial fibrosis (HP:0005576) | 1.84083604 |
| 182 | Metaphyseal cupping (HP:0003021) | 1.82236018 |
| 183 | Protuberant abdomen (HP:0001538) | 1.81408436 |
| 184 | Restrictive lung disease (HP:0002091) | 1.81312476 |
| 185 | Lip pit (HP:0100267) | 1.81081340 |
| 186 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80480628 |
| 187 | Interstitial pulmonary disease (HP:0006530) | 1.79944927 |
| 188 | Mucopolysacchariduria (HP:0008155) | 1.78790250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.85237582 |
| 2 | OXSR1 | 5.08164603 |
| 3 | STK39 | 4.45319675 |
| 4 | GRK7 | 3.85050643 |
| 5 | NME2 | 3.64262937 |
| 6 | RIPK1 | 3.51864978 |
| 7 | WNK3 | 3.48530878 |
| 8 | TAOK2 | 3.24747751 |
| 9 | MAP4K1 | 3.13651327 |
| 10 | ERN1 | 3.12839566 |
| 11 | DDR2 | 2.69997024 |
| 12 | PIM2 | 2.62293201 |
| 13 | MST4 | 2.52575097 |
| 14 | IKBKE | 2.47670393 |
| 15 | MOS | 2.44123943 |
| 16 | PRPF4B | 2.42858892 |
| 17 | LRRK2 | 2.29797959 |
| 18 | MATK | 2.27575670 |
| 19 | IRAK4 | 2.26223774 |
| 20 | LATS1 | 2.22305798 |
| 21 | GRK6 | 2.08815846 |
| 22 | MAP3K11 | 2.00438475 |
| 23 | TNK2 | 1.98453768 |
| 24 | BMPR2 | 1.96669126 |
| 25 | GRK1 | 1.96260598 |
| 26 | BCKDK | 1.81946658 |
| 27 | STK10 | 1.78236775 |
| 28 | WNK1 | 1.72634208 |
| 29 | TXK | 1.64121558 |
| 30 | MST1R | 1.62037834 |
| 31 | STK38L | 1.61860461 |
| 32 | CLK1 | 1.56885490 |
| 33 | MAP3K10 | 1.55002041 |
| 34 | CDK12 | 1.52958658 |
| 35 | FGFR4 | 1.47616125 |
| 36 | ADRBK2 | 1.40634217 |
| 37 | JAK1 | 1.40209412 |
| 38 | SIK1 | 1.37366017 |
| 39 | FGR | 1.36868903 |
| 40 | LATS2 | 1.35222679 |
| 41 | RIPK4 | 1.34939916 |
| 42 | MAP3K14 | 1.33622115 |
| 43 | MAP3K13 | 1.31167296 |
| 44 | PTK6 | 1.29256548 |
| 45 | BLK | 1.28699934 |
| 46 | IRAK1 | 1.25432907 |
| 47 | TAOK3 | 1.21649701 |
| 48 | FER | 1.21185312 |
| 49 | FRK | 1.19693877 |
| 50 | ACVR1B | 1.18882946 |
| 51 | TYK2 | 1.18548041 |
| 52 | BTK | 1.14954583 |
| 53 | CAMK1D | 1.07834347 |
| 54 | IRAK3 | 1.03979042 |
| 55 | TGFBR2 | 1.03276500 |
| 56 | ABL2 | 1.02668146 |
| 57 | PDK3 | 1.02046400 |
| 58 | PDK4 | 1.02046400 |
| 59 | MAP3K5 | 1.01439019 |
| 60 | IRAK2 | 1.01258115 |
| 61 | CSF1R | 0.98640434 |
| 62 | MAP3K7 | 0.98430221 |
| 63 | CAMK1G | 0.94673940 |
| 64 | PDK2 | 0.93747435 |
| 65 | ZAP70 | 0.92415517 |
| 66 | SIK2 | 0.91514553 |
| 67 | EEF2K | 0.90438279 |
| 68 | MAP3K1 | 0.90136254 |
| 69 | SYK | 0.89471366 |
| 70 | DYRK3 | 0.85548163 |
| 71 | MAP2K6 | 0.82668652 |
| 72 | MAP3K2 | 0.81066135 |
| 73 | STK38 | 0.79769693 |
| 74 | CDK6 | 0.79499849 |
| 75 | TESK2 | 0.75267787 |
| 76 | EPHB1 | 0.74330539 |
| 77 | EPHA3 | 0.73071597 |
| 78 | LCK | 0.70178072 |
| 79 | ITK | 0.69346696 |
| 80 | MAP3K3 | 0.69149800 |
| 81 | PKN1 | 0.68993236 |
| 82 | TRIB3 | 0.67892835 |
| 83 | SGK223 | 0.67398774 |
| 84 | SGK494 | 0.67398774 |
| 85 | TYRO3 | 0.66252690 |
| 86 | CSK | 0.66061800 |
| 87 | MAPK11 | 0.65120473 |
| 88 | PIK3CG | 0.64265361 |
| 89 | DYRK1B | 0.64181831 |
| 90 | SGK3 | 0.64148790 |
| 91 | HIPK2 | 0.64038482 |
| 92 | PDK1 | 0.63382483 |
| 93 | PRKD2 | 0.62069286 |
| 94 | BRD4 | 0.61712004 |
| 95 | PRKAA2 | 0.61372385 |
| 96 | MAPKAPK3 | 0.59563146 |
| 97 | LMTK2 | 0.58989946 |
| 98 | MAPK4 | 0.56957747 |
| 99 | MAPK12 | 0.52089673 |
| 100 | PRKCH | 0.51699902 |
| 101 | PDPK1 | 0.51686530 |
| 102 | BMX | 0.50930950 |
| 103 | CDK4 | 0.50333311 |
| 104 | CDC42BPA | 0.49922274 |
| 105 | TEC | 0.49518999 |
| 106 | LYN | 0.49202531 |
| 107 | TAOK1 | 0.49112589 |
| 108 | EIF2AK3 | 0.49064789 |
| 109 | JAK2 | 0.48379487 |
| 110 | PRKD1 | 0.47931967 |
| 111 | JAK3 | 0.47839067 |
| 112 | PKN2 | 0.47760538 |
| 113 | PRKAA1 | 0.47463199 |
| 114 | INSRR | 0.46657188 |
| 115 | STK3 | 0.46522163 |
| 116 | SGK2 | 0.46366731 |
| 117 | MARK3 | 0.45848070 |
| 118 | FGFR3 | 0.45665660 |
| 119 | PRKCQ | 0.44794651 |
| 120 | NEK9 | 0.43751572 |
| 121 | ABL1 | 0.42902975 |
| 122 | MTOR | 0.42340615 |
| 123 | PDGFRA | 0.41871918 |
| 124 | CHUK | 0.39607359 |
| 125 | INSR | 0.39499146 |
| 126 | TESK1 | 0.38601367 |
| 127 | DAPK3 | 0.37276768 |
| 128 | EIF2AK2 | 0.37126386 |
| 129 | GSK3A | 0.36626350 |
| 130 | KIT | 0.36181903 |
| 131 | HCK | 0.35894850 |
| 132 | FGFR2 | 0.35305002 |
| 133 | TBK1 | 0.34035832 |
| 134 | SGK1 | 0.33606813 |
| 135 | KDR | 0.33572383 |
| 136 | EGFR | 0.32094994 |
| 137 | PDGFRB | 0.31615825 |
| 138 | ARAF | 0.31583547 |
| 139 | CDK9 | 0.31559060 |
| 140 | IKBKB | 0.30881100 |
| 141 | PRKACG | 0.28843402 |
| 142 | MAPK7 | 0.26579425 |
| 143 | PRKCI | 0.26357529 |
| 144 | TLK1 | 0.26311838 |
| 145 | ICK | 0.25553809 |
| 146 | CDK14 | 0.25461128 |
| 147 | DAPK2 | 0.25231536 |
| 148 | STK11 | 0.24284229 |
| 149 | GRK5 | 0.24202909 |
| 150 | CDK15 | 0.23821362 |
| 151 | MAP2K3 | 0.22886210 |
| 152 | PIM1 | 0.22692222 |
| 153 | MAPKAPK2 | 0.22416308 |
| 154 | CDK11A | 0.22334605 |
| 155 | CDK18 | 0.18299647 |
| 156 | FYN | 0.17917919 |
| 157 | PRKCD | 0.17370450 |
| 158 | STK24 | 0.16966300 |
| 159 | CAMKK2 | 0.16593020 |
| 160 | MAPK3 | 0.16088626 |
| 161 | SIK3 | 0.13901046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20235470 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.01020348 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.86048018 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.84139149 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.75879457 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.73652046 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.60990121 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.58567959 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.56524100 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.56415361 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54186715 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44814475 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27818454 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.23196440 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.21504666 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18237305 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18123399 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.10502236 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10065465 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04734469 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.01516551 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.97843144 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95234722 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94956390 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.94510978 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94270794 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.94058223 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.91015799 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.90989705 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87662766 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76267084 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72273938 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71696353 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71645286 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66494576 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.64027327 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.63282964 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60709895 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59461423 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57613729 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.56213369 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50274891 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44707713 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42880070 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.42795769 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.41368451 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41101283 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.41014730 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39796868 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.36335991 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35258029 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30792211 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30408541 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26030950 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25619357 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23433113 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21806505 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.20129457 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17618013 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17012720 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.16779930 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16051755 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14361237 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13273992 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12026475 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10622543 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09923289 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09163589 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 1.02459817 |
| 70 | Measles_Homo sapiens_hsa05162 | 1.01539863 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98599496 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98326054 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96940081 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94800162 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94582970 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94150291 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93680489 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92951588 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90185300 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84456646 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82143688 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81510895 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80131444 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79482849 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78427099 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77745515 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77239766 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74709919 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73261259 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73101735 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72436802 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71841483 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.70283442 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68582199 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67999917 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67698470 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.64786846 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63425169 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63394892 |
| 100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61059022 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60495349 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59691817 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59618856 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58780582 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.57767266 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.53441620 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53109435 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.51467284 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50702324 |
| 110 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50074363 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49833576 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48960935 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48794411 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.47812088 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47382453 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46044218 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45673585 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45016711 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44917241 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.44283378 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43795044 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43736116 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.40590033 |
| 124 | Shigellosis_Homo sapiens_hsa05131 | 0.40367808 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39250690 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35331191 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34705962 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33847542 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32786218 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32404237 |
| 131 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31357674 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30339318 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.30204056 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28192221 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28083211 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27689793 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27442550 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26499283 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.26338979 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26318699 |
| 141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24970050 |
| 142 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23900036 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21874785 |
| 144 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20233465 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19805176 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19057859 |
| 147 | Tuberculosis_Homo sapiens_hsa05152 | 0.17561057 |
| 148 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17524621 |
| 149 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17243922 |
| 150 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16990815 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15303902 |

